Health Catalyst (HCAT) Cash & Equivalents (2018 - 2026)

Health Catalyst's Cash & Equivalents history runs 9 years deep, the most recent figure standing at $59.9 million for Q1 2026.

• Quarterly Cash & Equivalents fell 82.49% year-over-year to $59.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.9 million (down 82.49% YoY) and the FY2025 annual result came in at $50.8 million, down 79.65% from the prior year.
• Cash & Equivalents was $59.9 million for Q1 2026 at Health Catalyst, up from $50.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $342.0 million in Q1 2025 and bottomed at $40.3 million in Q3 2025.
• A 5-year average of $152.4 million and a median of $124.2 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 245.71% — and 2025, when it sank 87.72%.
• Health Catalyst's Cash & Equivalents stood at $116.3 million in 2022, then slipped by 8.63% to $106.3 million in 2023, then surged by 134.9% to $249.6 million in 2024, then plunged by 79.65% to $50.8 million in 2025, then grew by 17.81% to $59.9 million in 2026.
• Business Quant data shows HCAT's Cash & Equivalents at $59.9 million in Q1 2026, $50.8 million in Q4 2025, and $40.3 million in Q3 2025.